Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03491176

Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer

Quantification of Tumor Imaging Kinetics and Blood Biomarkers in Head and Neck Cancer Patients

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this research study is to find out if using additional MRIs and biomarker testing can help researchers learn to predict how the tumor may change during radiation therapy. Biomarkers are found in the blood/tissue and may be related to participant's reaction to treatment. Biomarker testing in the study may include genetic biomarkers. This is an investigational study. MRIs on this study are performed using FDA-approved and commercially available methods. Having added scans and blood tests is investigational. Up to 100 participants will be enrolled in this study (up to 80 patients and up to 20 healthy volunteers in another part of the study). All will take part at MD Anderson.

Detailed description

PRIMARY OBJECTIVES: I. To assess the prognostic value of pretreatment volumetric tumor growth velocity (TGV), weekly tumor kinetics (TK), and blood biomarkers of mucosal head and neck cancers during radiation therapy (RT), using magnetic resonance imaging (MRI). SECONDARY OBJECTIVES: I. To assess functional imaging kinetics as a marker of tumor locoregional control. II. To correlate blood biomarkers with tumor kinetics during treatment. III. To generate preliminary data for future trials. OUTLINE: Patients undergo MRI scans and collection of blood samples for biomarker testing pre-radiation therapy, weekly during radiation therapy, and at 2-3 months post-radiation therapy. After completion of study, patients are followed up weekly.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo collection of blood samples
PROCEDUREMagnetic Resonance ImagingUndergo MRI scan
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2017-05-18
Primary completion
2027-10-31
Completion
2027-10-31
First posted
2018-04-09
Last updated
2025-11-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03491176. Inclusion in this directory is not an endorsement.